Cognos Therapeutics Inc
PrivateLast Round
Seed Round
Jul 2, 2026
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Cognos Therapeutics Inc is a medical technology company developing the SINNAIS™, an implantable smart pump for targeted drug delivery to treat neurological diseases.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cognos Therapeutics Inc Comparables
Compare Cognos Therapeutics Inc with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Theracle | 88% | |
| CraniUS Therapeutics | 86% | |
| Precision NeuroMed | 85% | |
Cognos Therapeutics Inc Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Jul 2, 2026 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 2, 2026
$250K raised in Seed Round.
- Feb 24, 2025
Monthly visitors increased 72% MoM, reaching 1.7K.
Cognos Therapeutics Inc Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Cognos Therapeutics Inc's valuation, stock price, and market status.